South San Francisco, CA
Verge Genomics is a next-generation biopharmaceutical start-up using systems biology to accelerate development of life-saving treatments for neurodegenerative diseases.
vergegenomics.comThese are collections Verge Genomics is a part of. Click on the collection name to view similar companies.
Series B
$98,000,000
Series A
$32,000,000
Seed
$4,000,000
Pre Seed
$120,000
0 out of 5 stars
Based on 0 reviews
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Verge Genomics.